About Fertin Pharma
Fertin Pharma is a company based in Vejle (Denmark) founded in 1915 was acquired by Philip Morris International in July 2021. Fertin Pharma has raised $962.11 thousand across 3 funding rounds from investors including Philip Morris International, EQT and IFU. Fertin Pharma offers products and services including Zapliq®, Compressed gum, Extruded gum, Lozenge, and Pouches. Fertin Pharma operates in a competitive market with competitors including PharmaJet, Arecor, Suono Bio, Ensysce and Renovis, among others.
- Headquarter Vejle, Denmark
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Fertin Pharma A/S
-
Annual Revenue
Not available
-
Net Profit
-$108.06 (USD)30as on Dec 31, 2022
-
EBITDA
Not available
-
Total Equity Funding
$962.11 K (USD)
in 3 rounds
-
Latest Funding Round
$962.11 K (USD), Private Equity Round
Jun 01, 2014
-
Investors
Philip Morris International
& 3 more
-
Employee Count
Not available
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Fertin Pharma
Fertin Pharma offers a comprehensive portfolio of products and services, including Zapliq®, Compressed gum, Extruded gum, Lozenge, and Pouches.
Liquid-based system for effective pharmaceutical delivery.
Gum format for targeted active ingredient release.
Custom gum for nutraceutical applications.
Dissolvable form for pain and allergy management.
Container for vitamins and supplements delivery.
Chewable option for energy and sleep aids.
People of Fertin Pharma
Unlock access to complete
Funding Insights of Fertin Pharma
Fertin Pharma has successfully raised a total of $962.11K across 3 strategic funding rounds. The most recent funding activity was a Private Equity Round of $962.11 thousand completed in June 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Fertin Pharma
Fertin Pharma has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Philip Morris International, EQT and IFU.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investment firm
|
Locked | Locked | Locked | |
|
EQT is recognized as a global investment organization focused on value creation.
|
Locked | Locked | Locked | |
|
Administers health care and support for military personnel and operations.
|
Locked | Locked | Locked |
Investor details for Fertin Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Fertin Pharma
Investment portfolio details for Fertin Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Fertin Pharma
Detailed financials for Fertin Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Fertin Pharma Comparisons
Peer comparison for Fertin Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Fertin Pharma
Fertin Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PharmaJet, Arecor, Suono Bio, Ensysce and Renovis, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of needle-free injection technology
|
|
| Locked | Locked | Locked |
Developer of proteins, vaccines based on proprietary stabilization technologies for drug delivery
|
|
| Locked | Locked | Locked |
Developer of technology to enable ultra-rapid delivery of therapeutics to the gastrointestinal tract
|
|
| Locked | Locked | Locked |
Drug delivery solutions via single-walled carbon nanotubes are offered.
|
|
| Locked | Locked | Locked |
Drugs for neurological diseases are discovered and developed.
|
|
| Locked | Locked | Locked |
Provider of a proprietary platform for gene therapy
|
Detailed competitors of Fertin Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Fertin Pharma
Complete news archive for Fertin Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fertin Pharma
Fertin Pharma was founded in 1915 and raised its 1st funding round 93 years after it was founded.
Fertin Pharma is headquartered in Vejle, Denmark.
Soren Birn is the current CEO of Fertin Pharma.
Fertin Pharma is a funded company, having raised a total of $962.11K across 3 funding rounds to date.
Fertin Pharma was established in 1915 in Vejle, Denmark, within the pharmaceutical sector. Medicated chewing gum is developed and produced for various applications, utilizing a patented multi-layered compressed technology known as Medichew. Additional offerings include nutraceuticals, oral care items, multivitamins, and related products, with operations centered on manufacturing and innovation in oral delivery systems.
Fertin Pharma's top competitors include Oxular, PharmaJet and Splice Bio.
Fertin Pharma offers Zapliq®, Compressed gum, Extruded gum, Lozenge, and 2 more products and services.
Fertin Pharma has 4 investors. Key investors include Philip Morris International, EQT, IFU, and Military Health.